Table 2 Clinical findings in patients with TNET
From: Analysis of 25 surgical cases of thymic neuroendocrine tumors and thymic carcinoma
Age (years) /Sex | Histology | Tumor size (mm) | Preoperative therapy | Resection status | Combined resection | Masaoka stage | Postoperative therapy | Relapse site | Prognosis (Survival time, days) | ||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
CT | RT (Gy) | Effect | CT | RT (Gy) | |||||||||
1 | 58 M | Combined* | 45 | - | - | R2 | - | 4a | - | - | - | A(51) | |
2 | 51 M | LCNEC | 78 | - | - | R0 | L, PC, PN | 2 | - | - | Local | A(672) | |
3 | 83 M | Ac | 104 | - | - | R0 | PC | 2 | - | - | - | A(233) | |
4 | 68 M | LCNEC | 75 | - | - | R0 | L PC | 4a | ADOC | PRT | Distant | D(1410) | |
5 | 45 F | Ac | 62 | CDDP + VP-16 | 40 | PR | R0 | PC | 3 | SST, Ev | - | Distant | A(2912) |
6 | 61 M | Poorly | 65 | - | - | R0 | - | 2 | CDDP + VP-16 | - | - | A(2994) | |
7 | 70 M | Ac | 90 | - | - | R0 | BCV, PC | 4b | - | - | Local | A(3587) | |
8 | 54 M | SCC | 65 | - | - | R0 | L | 3 | CDDP + VP-16 | 50 Gy | Distant | D(3630) | |
9 | 50 M | SCC | 34 | CDDP + VP-16 + ADM | 45 | PR | R0 | - | 3 | - | - | - | A(4870) |